Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats

Journal of Psychopharmacology

Volumn 27, Issue 10, 2013, Pages 947-955

  Reich, Christian G ^a   Iskander, Anthony N ^a   Weiss, Michael S ^a  

^a RAMAPO COLLEGE OF NEW JERSEY   (United States)

Author keywords

CB1 receptor; depression; hippocampus; learning; PTSD

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN REGION; CHRONIC STRESS; CLINICAL PROTOCOL; CONDITIONING; CONTROLLED STUDY; EPISODIC MEMORY; FEAR CONDITIONING; HIPPOCAMPUS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECALL;

CB1 RECEPTOR; DEPRESSION; HIPPOCAMPUS; LEARNING; PTSD;

AGE FACTORS; ANIMALS; ARACHIDONIC ACIDS; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; MENTAL RECALL; RATS; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL;

EID: 84883868357     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113499207     Document Type: Article

References (55)

1. Arenos JD, Musty RE, Bucci DJ. Blockade of cannabinoid CB1 receptors alter contextual learning and memory. Eur J Pharmacol. 2006 ; 539: 177-183
2. Bouton M Learning and Behavior: A Contemporary Synthesis. Sunderland, MA: Sinauer ; 2007 :
3. Campbell S, MacQueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatr Neurosci. 2004 ; 29: 417-426
4. Chhatwal JP, Davis M, Maguschak KA, et al. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005 ; 30: 516-524
5. Clark RE, Manns JR, Squire LR. Trace and delay eyeblink conditioning: Contrasting phenomena of declarative and nondeclarative memory. Psychol Sci. 2001 ; 12: 304-308
6. Conrad CD. What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus?. Behav Cogn Neurosci Rev. 2006 ; 1: 41-60
7. Conrad CD, LeDoux JE, Magarinos AM, et al. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 1999 ; 113: 902-913
8. Cordero MI, Kruyt ND, Sandi C. Modulation of contextual fear conditioning by chronic stress in rats is related to individual differences in behavioral reactivity to novelty. Brain Res. 2003a ; 970: 242-245
9. Cordero MI, Venero C, Kruyt ND, et al. Prior exposure to a single stress session facilitates subsequent contextual fear conditioning in rats. Evidence for a role of corticosterone. Horm Behav. 2003b ; 44: 338-345
10. Dere E, Pause BM, Pietrowsky R. Emotion and episodic memory in neuropsychiatric disorders. Behav Brain Res. 2010 ; 215: 162-171
11. Fanselow MS. Conditioned and unconditional components of postshock freezing. Pavlov J Biol Sci. 1980 ; 15: 177-182
12. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress. 2009 ; 12: 1-21
13. Henningsen K, Andreasen JT, Bouzinova EV, et al. Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic-like responses. Behav Brain Res. 2009 ; 198: 136-141
14. Herman JP, Ostrander MM, Mueller NK, et al. Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-Adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry. 2005 ; 29: 1201-1213
15. Hill MN, Patel S, Campolongo P, et al. Functional interactions between stress and the endocannabinoid system: From synaptic signaling to behavioral output. J Neurosci. 2010 ; 30: 14980-14986
16. Hill MN, Gorzalka BB. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol Disord Drug Targets. 2009 ; 6: 451-458
17. Hill MN, Carrier EJ, McLaughlin RJ, et al. Regional alterations in the endocannabinoid system in an animal model of depression: Effects of concurrent antidepressant treatment. J Neurochem. 2008 ; 106: 2322-2336
18. Hill MN, Patel S, Carrier EJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 2005 ; 30: 508-515
19. Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci. 2002 ; 99: 8400-8405
20. Hu W, Zhang M, Czéh B, et al. Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats. Brain Res Bull. 2011 ; 85: 374-379
21. Jovanovic T, Ressler KJ. How the neurocircuitry and genetics of fear inhibition inform our understanding of PTSD. Am J Psychiatry. 2010 ; 167: 648-662
22. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the "kindling" hypothesis. Am J Psychiatry. 2000 ; 157: 1243-1251
23. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: An epidemiologic perspective. Biol Psychiatry. 2001 ; 49: 1002-1014
24. Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci. 2002 ; 3: 453-462
25. Krishnan V, Nestler EJ. Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry. 2010 ; 167: 1305-1320
26. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000 ; 23: 155-184
27. Lisboa SF, Reis DG, da Silva AL, et al. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol. 2010 ; 9: 1163-1173
28. Marsicano G, Wotjak CT, Azad SC, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002 ; 418: 530-534
29. Marin MT, Cruz FC, Planeta CS. Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats. Physiol Behav. 2007 ; 90: 29-35
30. McEwen BS. Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain. Metabolism. 2005 ; 54: 20-23
31. Moreira FA, Aguiar DC, Terzian AL, et al. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?. Neuroscience. 2012 ; 204: 186-192
32. Moreira FA, Wotjak CT. Cannabinoids and anxiety. Curr Top Behav Neurosci. 2010 ; 2: 429-450
33. Nieuwenhuis IL, Takashima A. The role of the ventromedial prefrontal cortex in memory consolidation. Behav Brain Res. 2011 ; 218: 325-334
34. Nopoulos P, Flaum M, Andreasen NC. Sex differences in brain morphology in schizophrenia. Am J Psychiatry. 1997 ; 154: 1648-1654
35. Pamplona FA, Takahashi RN. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett. 2006 ; 397: 88-92
36. Pamplona FA, Prediger RD, Pandolfo P, et al. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl). 2006 ; 188: 641-649
37. Patel S, Kingsley PJ, Mackie K, et al. Repeated homotypic stress elevates 2-Arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology. 2009 ; 34: 2699-2709
38. Pêgo JM, Morgado P, Pinto LG, et al. Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur Neurosci. 2008 ; 27: 1503-1516
39. Price TJ, Patwardhan A, Akopian AN, et al. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-Arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol. 2004 ; 141: 1118-1130
40. Rau V, DeCola JP, Fanselow MS. Stress-induced enhancement of fear learning: An animal model of posttraumatic stress disorder. Neurosci Biobehav Rev. 2005 ; 29: 1207-1223
41. Reich CG, Mohammadi M, Alger BE. Endocannabinoid modulation of fear responses: Learning performance and state-dependent effects. J Psychopharmacol. 2008 ; 22: 769-777
42. Reich CG, Taylor ME, McCarthy MM. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 2009 ; 203: 264-269
43. Sandi C, Merino JJ, Cordero MI, et al. Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its polysialylation, and L1. Neuroscience. 2001 ; 102: 329-339
44. Silveira PE, Silveira NA, Morini V, de C, et al. Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction. Neurosci Lett. 2010 ; 473: 97-101
45. Sink KS, Segovia KN, Collins LE, et al. The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacol Biochem Behav. 2010 ; 95: 479-484
46. Smart D, Gunthorpe MJ, Jerman JC, et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 2000 ; 129: 227-230
47. Sumislawski JJ, Ramikie TS, Patel S. Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: A potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology. 2011 ; 36: 2750-2761
48. Suzuki A, Josselyn SA, Frankland PW, et al. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci. 2004 ; 24: 4787-4795
49. Vyas A, Mitra R, Shankaranarayana Rao BS, et al. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002 ; 22: 6810-6818
50. Wamsteeker JI, Kuzmiski JB, Bains JS. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J Neurosci. 2010 ; 30: 11188-11196
51. Wang W, Sun D, Pan B, et al. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology. 2010 ; 35: 2249-2261
52. Willner P. Chronic mild stress (CMS) revisited: Consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005 ; 52: 90-110
53. Wong ML, Kling MA, Munson PJ, et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. PNAS. 2000 ; 97: 325-330
54. Yan HC, Cao X, Das M, et al. Behavioral animal models of depression. Neurosci Bull. 2010 ; 26: 327-337
55. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999 ; 400: 452-457